Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.

MLA

Ignatiadis, Michail, et al. “Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.” JAMA, Jan. 2025. EBSCOhost, https://doi.org/10.1001/jama.2024.26886.

APA

Ignatiadis, M., Bailey, A., McArthur, H., El-Abed, S., de Azambuja, E., Metzger, O., Chui, S. Y., Dieterich, M., Perretti, T., Shearer-Kang, E., Molinero, L., Steger, G. G., Jassem, J., Lee, S. C., Higgins, M., Zarba, J., Schmidt, M., Gomez, H., Guerrero Zotano, A., … Piccart, M. (2025). Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2024.26886

Chicago

Ignatiadis, Michail, Andrew Bailey, Heather McArthur, Sarra El-Abed, Evandro de Azambuja, Otto Metzger, Stephen Y Chui, et al. 2025. “Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.” JAMA, January. doi:10.1001/jama.2024.26886.